AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases

Journal

Science Translational Medicine

Journal Volume

8

Journal Issue

368

Date Issued

2016

Author(s)

Yang Z

Guo Q

Wang Y

Chen K

Zhang L

Cheng Z

Xu Y

Yin X

Bai Y

Rabbie S

Kim D.-W

Ahn M.-J

Zhang X.

DOI

10.1126/scitranslmed.aag0976

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85003467426&doi=10.1126%2fscitranslmed.aag0976&partnerID=40&md5=a6a0cb7b889f85e49917f1ae2fad738d

https://scholars.lib.ntu.edu.tw/handle/123456789/494965

SDGs

[SDGs]SDG3

Publisher

American Association for the Advancement of Science

Type

journal article